Desq Long
Sign in
SEC FORM 4
—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 208,125 shares; price not stated (see filing).

Reporting Person Kidron Miriam · Officer Title Chief Scientific Officer · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103536 · filed 2026-09-25 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "ORAMED PHARMACEUTICALS INC. (ORMP)." Disclosed 2026-09-25. https://desqlong.com/cards/0001213900-26-103536-1 (retrieved 2026-09-26).